Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-01-24
1978-06-13
Helfin, Bernard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424312, 424319, 260465D, 260516, 260519, 560 17, 560 43, 560 44, 560251, 560252, 560250, C07C10144, A61K 31195, A61K 3121
Patent
active
040949915
ABSTRACT:
New carboxylic acid derivatives are proposed for use as agents in the treatment of prevention of arteriosclerosis. 1-(p-chlorophenoxy)-3-(N-phenyl-N-carbomethoxymethylamino)-2-propanol is a typical compound.
REFERENCES:
patent: 3793365 (1974-02-01), Winter
patent: 3872147 (1975-03-01), Koppe
patent: 3935267 (1976-01-01), Hauck
Chokai Shoichi
Enomoto Hiroshi
Machara Mitsuhiro
Murai Hiromu
Ohata Katsuya
Helfin Bernard
Nippon Shinyaku Co. Ltd.
Shippen Michael L.
LandOfFree
Substituted N-(carboxymethyl)-3-aminopropan-2-ol derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted N-(carboxymethyl)-3-aminopropan-2-ol derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted N-(carboxymethyl)-3-aminopropan-2-ol derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-10282